Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Aurora Kinase A market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Aurora Kinase A market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Aurora Kinase A market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Aurora Kinase A products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Aurora Kinase A products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Aurora Kinase A market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Aurora Kinase A development has been the leading industry trend of Aurora Kinase A market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Aurora Kinase A Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
AMG-900,Danusertib,ENMD-2076,Ilorasertib,Others |
| By Application Outlook |
Ovarian Cancer,Anaplastic Large Cell Lymphoma,Brain Tumor,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
AbbVie Inc.,Amgen Inc.,Astex Pharmaceuticals, Inc.,CASI Pharmaceuticals Inc.,Merck & Co., Inc.,Millennium Pharmaceuticals, Inc.,Sanofi,Sareum Holdings Plc,Sigma-Tau S.p.A.,Taiho Pharmaceutical Co., Ltd.,Vertex Pharmaceuticals Incorporated,Vichem Chemie Research Ltd. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- AbbVie Inc.
- Amgen Inc.
- Astex Pharmaceuticals
- Inc.
- CASI Pharmaceuticals Inc.
- Merck & Co.
- Inc.
- Millennium Pharmaceuticals
- Inc.
- Sanofi
- Sareum Holdings Plc
- Sigma-Tau S.p.A.
- Taiho Pharmaceutical Co.
- Ltd.
- Vertex Pharmaceuticals Incorporated
- Vichem Chemie Research Ltd.
Aurora Kinase A Market, By Type
- AMG-900
- Danusertib
- ENMD-2076
- Ilorasertib
- Others
Aurora Kinase A Market, By Application
- Ovarian Cancer
- Anaplastic Large Cell Lymphoma
- Brain Tumor
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Aurora Kinase A Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Aurora Kinase A Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 AMG-900 Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Danusertib Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 ENMD-2076 Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Ilorasertib Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.5 Others Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Aurora Kinase A Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Aurora Kinase A Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Aurora Kinase A Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Aurora Kinase A Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Aurora Kinase A Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Aurora Kinase A Market Assessment by Type
8.1 Asia Pacific Aurora Kinase A Market Assessment by Application (Consumption and Market Share)
8.2 North America Aurora Kinase A Market Assessment by Application (Consumption and Market Share)
8.3 Europe Aurora Kinase A Market Assessment by Application (Consumption and Market Share)
8.4 South America Aurora Kinase A Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Aurora Kinase A Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 AbbVie Inc.
9.1.1 AbbVie Inc. Profiles
9.1.2 AbbVie Inc. Product Portfolio
9.1.3 AbbVie Inc. Aurora Kinase A Business Performance
9.1.4 AbbVie Inc. Aurora Kinase A Business Development and Market Status
9.2 Amgen Inc.
9.2.1 Amgen Inc. Profiles
9.2.2 Amgen Inc. Product Portfolio
9.2.3 Amgen Inc. Aurora Kinase A Business Performance
9.2.4 Amgen Inc. Aurora Kinase A Business Development and Market Status
9.3 Astex Pharmaceuticals, Inc.
9.3.1 Astex Pharmaceuticals, Inc. Profiles
9.3.2 Astex Pharmaceuticals, Inc. Product Portfolio
9.3.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Business Performance
9.3.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Business Development and Market Status
9.4 CASI Pharmaceuticals Inc.
9.4.1 CASI Pharmaceuticals Inc. Profiles
9.4.2 CASI Pharmaceuticals Inc. Product Portfolio
9.4.3 CASI Pharmaceuticals Inc. Aurora Kinase A Business Performance
9.4.4 CASI Pharmaceuticals Inc. Aurora Kinase A Business Development and Market Status
9.5 Merck & Co., Inc.
9.5.1 Merck & Co., Inc. Profiles
9.5.2 Merck & Co., Inc. Product Portfolio
9.5.3 Merck & Co., Inc. Aurora Kinase A Business Performance
9.5.4 Merck & Co., Inc. Aurora Kinase A Business Development and Market Status
9.6 Millennium Pharmaceuticals, Inc.
9.6.1 Millennium Pharmaceuticals, Inc. Profiles
9.6.2 Millennium Pharmaceuticals, Inc. Product Portfolio
9.6.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Business Performance
9.6.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Business Development and Market Status
9.7 Sanofi
9.7.1 Sanofi Profiles
9.7.2 Sanofi Product Portfolio
9.7.3 Sanofi Aurora Kinase A Business Performance
9.7.4 Sanofi Aurora Kinase A Business Development and Market Status
9.8 Sareum Holdings Plc
9.8.1 Sareum Holdings Plc Profiles
9.8.2 Sareum Holdings Plc Product Portfolio
9.8.3 Sareum Holdings Plc Aurora Kinase A Business Performance
9.8.4 Sareum Holdings Plc Aurora Kinase A Business Development and Market Status
9.9 Sigma-Tau S.p.A.
9.9.1 Sigma-Tau S.p.A. Profiles
9.9.2 Sigma-Tau S.p.A. Product Portfolio
9.9.3 Sigma-Tau S.p.A. Aurora Kinase A Business Performance
9.9.4 Sigma-Tau S.p.A. Aurora Kinase A Business Development and Market Status
9.10 Taiho Pharmaceutical Co., Ltd.
9.10.1 Taiho Pharmaceutical Co., Ltd. Profiles
9.10.2 Taiho Pharmaceutical Co., Ltd. Product Portfolio
9.10.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Business Performance
9.10.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Business Development and Market Status
9.11 Vertex Pharmaceuticals Incorporated
9.12 Vichem Chemie Research Ltd.
10 World Aurora Kinase A Market Assessment by Players
10.1 Global Aurora Kinase A Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Aurora Kinase A Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Aurora Kinase A Price (USD/Unit) of Players 2014-2020
10.4 Global Aurora Kinase A Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Aurora Kinase A Sales Assessment of Players 2014-2020
11.1.2 North America Aurora Kinase A Revenue Assessment of Players 2014-2020
11.1.3 North America Aurora Kinase A Price Assessment of Players 2014-2020
11.1.4 North America Aurora Kinase A Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Aurora Kinase A Sales Assessment of Players 2014-2020
11.2.2 Europe Aurora Kinase A Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Aurora Kinase A Price Assessment of Players 2014-2020
11.2.4 Europe Aurora Kinase A Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Aurora Kinase A Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Aurora Kinase A Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Aurora Kinase A Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Aurora Kinase A Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Aurora Kinase A Sales Assessment of Players 2014-2020
11.4.2 South America Aurora Kinase A Revenue Assessment of Players 2014-2020
11.4.3 South America Aurora Kinase A Price Assessment of Players 2014-2020
11.4.4 South America Aurora Kinase A Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Aurora Kinase A Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Aurora Kinase A Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Aurora Kinase A Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Aurora Kinase A Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Aurora Kinase A Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Aurora Kinase A Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Aurora Kinase A Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Aurora Kinase A Sales by Countries/Regions 2014-2020
12.2.2 North America Aurora Kinase A Revenue by Countries/Regions 2014-2020
12.2.3 North America Aurora Kinase A Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Aurora Kinase A Sales by Countries/Regions 2014-2020
12.3.2 Europe Aurora Kinase A Revenue by Countries/Regions 2014-2020
12.3.3 Europe Aurora Kinase A Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Aurora Kinase A Sales by Countries/Regions 2014-2020
12.4.2 South America Aurora Kinase A Revenue by Countries/Regions 2014-2020
12.4.3 South America Aurora Kinase A Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Aurora Kinase A Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Aurora Kinase A Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Aurora Kinase A Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Aurora Kinase A Sales & Revenue Forecast 2021-2026
14.1 World Aurora Kinase A Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Aurora Kinase ASales and Market Share by Regions
14.1.2 World Aurora Kinase ARevenue and Market Share by Regions
15 Asia Aurora Kinase A Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 AMG-900
15.1.2 Danusertib
15.1.3 ENMD-2076
15.1.4 Ilorasertib
15.1.5 Others
15.2 Consumption Forecast by Application, 2021-2026
16 North America Aurora Kinase A Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 AMG-900
16.1.2 Danusertib
16.1.3 ENMD-2076
16.1.4 Ilorasertib
16.1.5 Others
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Aurora Kinase A Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 AMG-900
17.1.2 Danusertib
17.1.3 ENMD-2076
17.1.4 Ilorasertib
17.1.5 Others
17.2 Consumption Forecast by Application, 2021-2026
18 South America Aurora Kinase A Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 AMG-900
18.1.2 Danusertib
18.1.3 ENMD-2076
18.1.4 Ilorasertib
18.1.5 Others
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Aurora Kinase A Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 AMG-900
19.1.2 Danusertib
19.1.3 ENMD-2076
19.1.4 Ilorasertib
19.1.5 Others
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Aurora Kinase A Price (USD/Unit) Trend 2021-2026
20.2 Global Aurora Kinase A Gross Profit Trend 2021-2026
21 Conclusion
